However, while Tirzepatide presents promising benefits, it is essential for patients to be aware of potential side effects, which can include gastrointestinal issues such as nausea, diarrhea, constipation, and vomiting
Indirect comparisons suggest it is more effective compared with semaglutide alongside diet and exercise support. Semaglutide, which is better known as Wegovy, was the first anti-obesity drug that Nice approved, back in 2022
Cerovecki T, Bojanic I, et al
Athenas educational foundation, including a Bachelor of Science in Nursing from Xavier University and a Master of Science in Nursing from Northern Kentucky University, reflects her dedication to excellence and professional development
Average weight loss in the treatment group was 13.6% body weight, compared to 2.4% in the placebo group
While many factors can cause this problem, research suggests that glutathione injection side effects could be one of them